Prevention of Kidney Transplant Rejection
End-Stage Renal Disease, Chronic Allograft Nephropathy
About this trial
This is an interventional treatment trial for End-Stage Renal Disease
Eligibility Criteria
Inclusion Criteria You may be eligible for this study if you: Are at least 18 years old. Received a kidney transplant at least 1 year prior to study entry. Have been diagnosed with chronic rejection following kidney transplant and within 6 months prior to study entry. Have been receiving a stable immunosuppressive medication regimen for 1 month prior to study entry that includes at least cyclosporine or tacrolimus and prednisone. Have high blood pressure. Agree to use an effective method of birth control during the study. Exclusion Criteria You will not be eligible for this study if you: Are participating in another study with required tests or treatments. Cannot take ACE inhibitors or HMG-CoA reductase inhibitors. Absolutely must take ACE inhibitors or HMG-CoA reductase inhibitors. Have a serious disease or medical condition. Are pregnant.
Sites / Locations
- Ilene Blechman-Krom